<?xml version="1.0" encoding="utf-8" ?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN"
                  "JATS-publishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.2" article-type="other">
<front>
<journal-meta>
<journal-id></journal-id>
<journal-title-group>
<journal-title>Journal of Open Source Software</journal-title>
<abbrev-journal-title>JOSS</abbrev-journal-title>
</journal-title-group>
<issn publication-format="electronic">2475-9066</issn>
<publisher>
<publisher-name>Open Journals</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">8266</article-id>
<article-id pub-id-type="doi">10.21105/joss.08266</article-id>
<title-group>
<article-title>substrateminer: A Python package to investigate protein
substrate repertoires</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4569-6921</contrib-id>
<name>
<surname>QIAO</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="aff-1"/>
<xref ref-type="aff" rid="aff-2"/>
</contrib>
<aff id="aff-1">
<institution-wrap>
<institution>School of Biological Sciences, Flinders University, Bedford
Park, SA 5042, Australia</institution>
</institution-wrap>
</aff>
<aff id="aff-2">
<institution-wrap>
<institution>Digital Research Services, Flinders University, Bedford
Park, SA 5042, Australia</institution>
</institution-wrap>
</aff>
</contrib-group>
<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2024-08-29">
<day>29</day>
<month>8</month>
<year>2024</year>
</pub-date>
<volume>10</volume>
<issue>113</issue>
<fpage>8266</fpage>
<permissions>
<copyright-statement>Authors of papers retain copyright and release the
work under a Creative Commons Attribution 4.0 International License (CC
BY 4.0)</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>The article authors</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>Authors of papers retain copyright and release the work under
a Creative Commons Attribution 4.0 International License (CC BY
4.0)</license-p>
</license>
</permissions>
<kwd-group kwd-group-type="author">
<kwd>Python</kwd>
<kwd>visualisation</kwd>
<kwd>enzyme</kwd>
<kwd>proteolysis</kwd>
<kwd>substrates</kwd>
<kwd>bioinformatics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="summary">
  <title>Summary</title>
  <p><monospace>Substrateminer</monospace> is a Python library that
  provides a suite of modular investigative methods based on protein
  sequence and cellular properties to support rapid development of
  <italic>in silico</italic> pipelines to discover and interrogate
  potential substrates for a target protease of interest. Three
  categories of methods are included in
  <monospace>substrateminer</monospace>: consensus analysis, substrate
  mining, and pathological investigation. Together, they provide a
  well-suited toolkit to explore substrate repertoires, also known as
  the substrate degradome, for a target protease.</p>
</sec>
<sec id="statement-of-need">
  <title>Statement of need</title>
  <p>The ability to identify and discover novel protease <italic>in
  situ</italic> substrates is often a powerful first step towards
  understanding the biological functions of proteases and their
  implications in human health and disease. However, in traditional
  enzymology, substrates of a target enzyme are studied one at a time,
  arguably due to the prohibitive cost involved in designing and
  deploying large-scale experimental assays. Modern proteomics methods,
  particularly the advancement in mass spectrometry, drastically reduce
  the cost associated with detecting substrate hydrolysis events at the
  molecular level, and now the study of substrates of a target enzyme at
  the proteome level is no longer a distant fantasy. With these new
  possibilities, the lack of a modular system to enable rapid
  development of <italic>in silico</italic> pipelines to support
  preliminary discovery has been a bottleneck for new studies.
  Therefore, <monospace>substrateminer</monospace> aims to provide a
  versatile toolkit that enables fast modular development of <italic>in
  silico</italic> pipelines to facilitate the preliminary discovery that
  complements and accelerates the emerging experimental efforts.</p>
</sec>
<sec id="background">
  <title>Background</title>
  <p>Proteolytic cleavage is a fundamental biochemical process in
  biology, which underpins many important biological processes that
  surround us from common food processing and digestion
  (<xref alt="Campbell &amp; Reece, 2005" rid="ref-campbell2005biology" ref-type="bibr">Campbell
  &amp; Reece, 2005</xref>) to protective immune responses against
  pathogen infections
  (<xref alt="Kammerl &amp; Meiners, 2016" rid="ref-ajplung001562016" ref-type="bibr">Kammerl
  &amp; Meiners, 2016</xref>). Almost all proteolytic processes in
  nature are catalysed by enzymes, and proteases are such an enzyme
  class that facilitates the biochemical reaction of cleaving peptide
  bonds. The inhibition of proteases has been a major intervention
  strategy in modern clinics to modulate molecular proteolytic processes
  to treat many physiological conditions including viral infections like
  HIV, hepatitis-C; metabolic dysfunctions like type-2 diabetes
  (<xref alt="Scott, 2017" rid="ref-Scott2017" ref-type="bibr">Scott,
  2017</xref>); and cancers
  (<xref alt="Manasanch &amp; Orlowski, 2017" rid="ref-Manasanch2017" ref-type="bibr">Manasanch
  &amp; Orlowski, 2017</xref>). In the wake of the COVID-19 pandemic,
  proteases have emerged as a major therapeutic target for curbing
  fatality due to viral infections
  (<xref alt="Borges et al., 2024" rid="ref-v16030366" ref-type="bibr">Borges
  et al., 2024</xref>;
  <xref alt="Papaneophytou, 2024" rid="ref-ijms25158105" ref-type="bibr">Papaneophytou,
  2024</xref>;
  <xref alt="Sojka et al., 2021" rid="ref-ijms22115762" ref-type="bibr">Sojka
  et al., 2021</xref>).</p>
  <p>Nevertheless, one constraining factor that confronts the rapid
  development of protease inhibitory therapy is the undiscriminating
  nature of inhibition. This is a major challenge because most proteases
  are involved in a complex network of biological processes, and a
  complete inhibition of one protease can lead to unintended
  consequences on many other biological processes. Therefore,
  identifying and understanding the substrate degradome of a target
  protease is an important preliminary step towards inhibitory therapy.
  Traditionally, the identification of protease substrates is often
  challenging due to the prohibitive cost of large-scale deployment of
  target-designed immuno-based biochemistry assays and scarcity of
  adequate animal models. Modern advancements in proteomics,
  particularly the maturation of mass spectrometry
  (<xref alt="Han et al., 2008" rid="ref-HAN2008483" ref-type="bibr">Han
  et al., 2008</xref>) and soft-ionisation methods
  (<xref alt="Challen &amp; Cramer, 2022" rid="ref-Challen202100394" ref-type="bibr">Challen
  &amp; Cramer, 2022</xref>), started to become a cost-effective
  alternative in the identification of protease substrates at a proteome
  level. Therefore, the ability to rapidly develop <italic>in
  silico</italic> pipelines to support preliminary discovery of protease
  substrates is increasingly needed to complement the emerging
  experimental efforts.</p>
</sec>
<sec id="methods">
  <title>Methods</title>
  <p><monospace>Substrateminer</monospace> contains three main classes
  of functions (with a schematic depicted in
  <xref alt="[fig:workflow]" rid="figU003Aworkflow">[fig:workflow]</xref>),
  namely consensus investigation (via submodules msa and consensus),
  substrate mining (via submodule miner) and substrate biopathological
  pathway searching (via submodule pathfinder).</p>
  <fig>
    <caption><p>Substrateminer
    workflow<styled-content id="figU003Aworkflow"></styled-content></p></caption>
    <graphic mimetype="image" mime-subtype="png" xlink:href="workflow.png" />
  </fig>
  <p>A typical workflow for adopting
  <monospace>substrateminer</monospace> to investigate substrate
  degradome for a given protease often involves the following three main
  stages:</p>
  <sec id="consensus-investigation">
    <title>Consensus investigation</title>
    <p><monospace>Substrateminer</monospace> provides a mechanism to
    visualise the cleavage consensus motif and calculate the strength of
    conservation at each site along the motif. The strength of
    conservation is calculated based on entropy, and
    <monospace>substrateminer</monospace> is also packaged with
    auxiliary tools to provide multi-sequence alignment (MSA) access to
    help prepare the input data for consensus investigation. Consensus
    visualisation is created by calling an implementation of weblogo
    (<xref alt="Crooks et al., 2004" rid="ref-Crooks01062004" ref-type="bibr">Crooks
    et al., 2004</xref>).
    (<xref alt="[fig:weblogo]" rid="figU003Aweblogo">[fig:weblogo]</xref>)</p>
    <p>As of the current release, <monospace>substrateminer</monospace>
    supports two popular multi-alignment tools for proteins, namely
    <monospace>MUSCLE</monospace> (default)
    (<xref alt="Edgar, 2004" rid="ref-gkh340" ref-type="bibr">Edgar,
    2004</xref>) and <monospace>MAFFT</monospace>
    (<xref alt="Katoh et al., 2002" rid="ref-gkf436" ref-type="bibr">Katoh
    et al., 2002</xref>), while the Linux distribution supports
    additional implementation of <monospace>ClustalO</monospace>
    (<xref alt="Sievers &amp; Higgins, 2014" rid="ref-bi0313s48" ref-type="bibr">Sievers
    &amp; Higgins, 2014</xref>). The cleavage motif consensus is
    calculated based on the frequency of amino acid residues at each
    position along the motif, and the visualisation is proportional to
    the information content at each site. The information content
    <inline-formula><alternatives>
    <tex-math><![CDATA[R]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>R</mml:mi></mml:math></alternatives></inline-formula>
    at position <inline-formula><alternatives>
    <tex-math><![CDATA[i]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>i</mml:mi></mml:math></alternatives></inline-formula>
    for protein is defined by
    <xref alt="Equation 1" rid="eqU003Ainformation_content">Equation 1</xref>:</p>
    <p><named-content id="eqU003Ainformation_content" content-type="equation"><disp-formula><alternatives>
    <tex-math><![CDATA[
    R_i = -\log_2(20) - H(X_i)]]></tex-math>
    <mml:math display="block" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>−</mml:mi><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true" form="prefix">(</mml:mo><mml:mn>20</mml:mn><mml:mo stretchy="true" form="postfix">)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="true" form="prefix">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="true" form="postfix">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula></named-content></p>
    <p>The strength of conservation is calculated based on Shannon
    entropy
    (<xref alt="Shannon, 1948" rid="ref-Shannon6773024" ref-type="bibr">Shannon,
    1948</xref>) with the formulation in
    <xref alt="Equation 2" rid="eqU003Aentropy">Equation 2</xref>, and
    the consensus motif is defined as the most frequent amino acid
    residue at each position along the motif.</p>
    <p><named-content id="eqU003Aentropy" content-type="equation"><disp-formula><alternatives>
    <tex-math><![CDATA[
    H(X) = -\sum_{i=1}^{n} p_i \log_2 p_i]]></tex-math>
    <mml:math display="block" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy="true" form="prefix">(</mml:mo><mml:mi>X</mml:mi><mml:mo stretchy="true" form="postfix">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>−</mml:mi><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></disp-formula></named-content></p>
    <fig>
      <caption><p>Consensus investigation - Visualisation
      Example<styled-content id="figU003Aweblogo"></styled-content></p></caption>
      <graphic mimetype="image" mime-subtype="png" xlink:href="weblogo-2.png" />
    </fig>
  </sec>
  <sec id="substrate-mining">
    <title>Substrate mining</title>
    <p>Upon the identification of a cleavage consensus,
    <monospace>substrateminer</monospace> provides a mechanism to mine
    potential substrates based on three filter strategies:</p>
    <list list-type="order">
      <list-item>
        <p><italic>Cellular location</italic>: filter potential
        substrates based on the cellular localisation of the intended
        target. For example, if the target protease is a secreted
        protease, the substrates mined should be extracellular
        proteins.</p>
      </list-item>
      <list-item>
        <p><italic>Target Size</italic>: filter potential substrates
        based on the size of the intended target. For example, if the
        target substrate is a small protease, the substrates mined
        should be small proteins or peptides of a specified size.</p>
      </list-item>
      <list-item>
        <p><italic>Consensus</italic>: filter potential substrates based
        on the conservation of the cleavage consensus. In the current
        release, both intra-protein cleavage (i.e., endopeptidase) and
        terminal cleavage (both C and N-terminal) (i.e., exopeptidase)
        consensus are supported.</p>
      </list-item>
    </list>
  </sec>
  <sec id="substrate-pathobiological-pathway-searching">
    <title>Substrate pathobiological pathway searching</title>
    <p>To further investigate the pathobiological relevance of novel
    substrates, <monospace>substrateminer</monospace> implements a
    search strategy to retrieve known biological processes and disease
    associations based on the <italic>de facto</italic> standard KEGG
    database
    (<xref alt="Kanehisa, 2019" rid="ref-pro3715" ref-type="bibr">Kanehisa,
    2019</xref>;
    <xref alt="Kanehisa &amp; Goto, 2000" rid="ref-10.1093" ref-type="bibr">Kanehisa
    &amp; Goto, 2000</xref>). In the present release, the
    <monospace>pathfinder</monospace> module in the
    <monospace>substrateminer</monospace> provides three main functions,
    namely KEGG accession conversion, biological processes tracing and
    human disease mapping, where KEGG accession conversion enables a
    gateway to KEGG databases, where further information, including
    enzyme nomenclature and disease-related network databases, can be
    easily accessed. Biological processes tracing allows users to trace
    the biological processes associated with a given substrate, and
    human disease mapping enables users to map the potential substrates
    to known human diseases based on the KEGG disease database.</p>
    <p>As of the current release, the <monospace>pathfinder</monospace>
    submodule queries all 580 KEGG molecular pathway maps and covers
    1205 eukaryotes, 9375 bacteria and 449 archaea
    (<xref alt="Kanehisa &amp; Goto, 2025" rid="ref-kegg_statistics_2025" ref-type="bibr">Kanehisa
    &amp; Goto, 2025</xref>). Nevertheless, the diseases covered are
    limited to the human context.</p>
  </sec>
</sec>
<sec id="limitations">
  <title>Limitations</title>
  <p>The current release of <monospace>substrateminer</monospace> is
  limited to the investigation of protease substrates based on substrate
  primary sequence consensus in model organisms. In cases where
  proteases have very loose consensus, like metalloproteinase ADAM10
  (<xref alt="Caescu et al., 2009" rid="ref-CaescuBJ20090549" ref-type="bibr">Caescu
  et al., 2009</xref>) that is arguably best-known for its protective
  effects in prion diseases like mad cow disease in cattle, additional
  structural factors and contexts may need to be taken into
  consideration. Additionally, the efficacy of the
  <monospace>substrateminer</monospace> investigative power expanding
  beyond well-studied organisms is limited by the availability of a
  comprehensive proteome database for the underlying species. In the
  future, we aim to expand the scope of
  <monospace>substrateminer</monospace> to scrutinise substrate
  structural characteristics and provide a more comprehensive suite of
  tools for substrate investigation.</p>
</sec>
<sec id="conflict-of-interests">
  <title>Conflict of Interests</title>
  <p>The author declares no conflict of interest.</p>
</sec>
</body>
<back>
<ref-list>
  <title></title>
  <ref id="ref-campbell2005biology">
    <element-citation publication-type="book">
      <person-group person-group-type="author">
        <name><surname>Campbell</surname><given-names>N. A.</given-names></name>
        <name><surname>Reece</surname><given-names>J. B.</given-names></name>
      </person-group>
      <source>Biology</source>
      <publisher-name>Pearson, Benjamin Cummings</publisher-name>
      <year iso-8601-date="2005">2005</year>
      <isbn>9780805371710</isbn>
      <uri>https://books.google.com.au/books?id=0jbm8J7VW0AC</uri>
    </element-citation>
  </ref>
  <ref id="ref-ajplung001562016">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Kammerl</surname><given-names>Ilona E.</given-names></name>
        <name><surname>Meiners</surname><given-names>Silke</given-names></name>
      </person-group>
      <article-title>Proteasome function shapes innate and adaptive immune responses</article-title>
      <source>American Journal of Physiology-Lung Cellular and Molecular Physiology</source>
      <year iso-8601-date="2016">2016</year>
      <volume>311</volume>
      <issue>2</issue>
      <uri>https://doi.org/10.1152/ajplung.00156.2016</uri>
      <pub-id pub-id-type="doi">10.1152/ajplung.00156.2016</pub-id>
      <fpage>L328</fpage>
      <lpage>L336</lpage>
    </element-citation>
  </ref>
  <ref id="ref-ijms25158105">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Papaneophytou</surname><given-names>Christos</given-names></name>
      </person-group>
      <article-title>Breaking the chain: Protease inhibitors as game changers in respiratory viruses management</article-title>
      <source>International Journal of Molecular Sciences</source>
      <year iso-8601-date="2024">2024</year>
      <volume>25</volume>
      <issue>15</issue>
      <issn>1422-0067</issn>
      <uri>https://www.mdpi.com/1422-0067/25/15/8105</uri>
      <pub-id pub-id-type="doi">10.3390/ijms25158105</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-v16030366">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Borges</surname><given-names>Pedro Henrique Oliveira</given-names></name>
        <name><surname>Ferreira</surname><given-names>Sabrina Baptista</given-names></name>
        <name><surname>Silva</surname><given-names>Floriano Paes</given-names></name>
      </person-group>
      <article-title>Recent advances on targeting proteases for antiviral development</article-title>
      <source>Viruses</source>
      <year iso-8601-date="2024">2024</year>
      <volume>16</volume>
      <issue>3</issue>
      <issn>1999-4915</issn>
      <uri>https://www.mdpi.com/1999-4915/16/3/366</uri>
      <pub-id pub-id-type="doi">10.3390/v16030366</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-ijms22115762">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Sojka</surname><given-names>Daniel</given-names></name>
        <name><surname>Šnebergerová</surname><given-names>Pavla</given-names></name>
        <name><surname>Robbertse</surname><given-names>Luïse</given-names></name>
      </person-group>
      <article-title>Protease inhibition—an established strategy to combat infectious diseases</article-title>
      <source>International Journal of Molecular Sciences</source>
      <year iso-8601-date="2021">2021</year>
      <volume>22</volume>
      <issue>11</issue>
      <issn>1422-0067</issn>
      <uri>https://www.mdpi.com/1422-0067/22/11/5762</uri>
      <pub-id pub-id-type="doi">10.3390/ijms22115762</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-Scott2017">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Scott</surname><given-names>Lesley J</given-names></name>
      </person-group>
      <article-title>Sitagliptin: A review in type 2 diabetes</article-title>
      <source>Drugs</source>
      <year iso-8601-date="2017">2017</year>
      <volume>77</volume>
      <issn>1179-1950</issn>
      <uri>https://doi.org/10.1007/s40265-016-0686-9</uri>
      <pub-id pub-id-type="doi">10.1007/s40265-016-0686-9</pub-id>
      <fpage>209</fpage>
      <lpage>224</lpage>
    </element-citation>
  </ref>
  <ref id="ref-Manasanch2017">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Manasanch</surname><given-names>Elisabet E</given-names></name>
        <name><surname>Orlowski</surname><given-names>Robert Z</given-names></name>
      </person-group>
      <article-title>Proteasome inhibitors in cancer therapy</article-title>
      <source>Nature Reviews Clinical Oncology</source>
      <year iso-8601-date="2017">2017</year>
      <volume>14</volume>
      <issn>1759-4782</issn>
      <uri>https://doi.org/10.1038/nrclinonc.2016.206</uri>
      <pub-id pub-id-type="doi">10.1038/nrclinonc.2016.206</pub-id>
      <fpage>417</fpage>
      <lpage>433</lpage>
    </element-citation>
  </ref>
  <ref id="ref-Crooks01062004">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Crooks</surname><given-names>Gavin E.</given-names></name>
        <name><surname>Hon</surname><given-names>Gary</given-names></name>
        <name><surname>Chandonia</surname><given-names>John-Marc</given-names></name>
        <name><surname>Brenner</surname><given-names>Steven E.</given-names></name>
      </person-group>
      <article-title>WebLogo: A sequence logo generator</article-title>
      <source>Genome Research</source>
      <year iso-8601-date="2004">2004</year>
      <volume>14</volume>
      <issue>6</issue>
      <uri>http://genome.cshlp.org/content/14/6/1188.abstract</uri>
      <pub-id pub-id-type="doi">10.1101/gr.849004</pub-id>
      <fpage>1188</fpage>
      <lpage>1190</lpage>
    </element-citation>
  </ref>
  <ref id="ref-10.1093">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Kanehisa</surname><given-names>Minoru</given-names></name>
        <name><surname>Goto</surname><given-names>Susumu</given-names></name>
      </person-group>
      <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>
      <source>Nucleic Acids Research</source>
      <year iso-8601-date="2000-01">2000</year><month>01</month>
      <volume>28</volume>
      <issue>1</issue>
      <issn>0305-1048</issn>
      <uri>https://doi.org/10.1093/nar/28.1.27</uri>
      <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id>
      <fpage>27</fpage>
      <lpage>30</lpage>
    </element-citation>
  </ref>
  <ref id="ref-pro3715">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Kanehisa</surname><given-names>Minoru</given-names></name>
      </person-group>
      <article-title>Toward understanding the origin and evolution of cellular organisms</article-title>
      <source>Protein Science</source>
      <year iso-8601-date="2019">2019</year>
      <volume>28</volume>
      <issue>11</issue>
      <uri>https://onlinelibrary.wiley.com/doi/abs/10.1002/pro.3715</uri>
      <pub-id pub-id-type="doi">10.1002/pro.3715</pub-id>
      <fpage>1947</fpage>
      <lpage>1951</lpage>
    </element-citation>
  </ref>
  <ref id="ref-CaescuBJ20090549">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Caescu</surname><given-names>Cristina I.</given-names></name>
        <name><surname>Jeschke</surname><given-names>Grace R.</given-names></name>
        <name><surname>Turk</surname><given-names>Benjamin E.</given-names></name>
      </person-group>
      <article-title>Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10</article-title>
      <source>Biochemical Journal</source>
      <year iso-8601-date="2009-10">2009</year><month>10</month>
      <volume>424</volume>
      <issue>1</issue>
      <issn>0264-6021</issn>
      <uri>https://doi.org/10.1042/BJ20090549</uri>
      <pub-id pub-id-type="doi">10.1042/BJ20090549</pub-id>
      <fpage>79</fpage>
      <lpage>88</lpage>
    </element-citation>
  </ref>
  <ref id="ref-kegg_statistics_2025">
    <element-citation>
      <person-group person-group-type="author">
        <name><surname>Kanehisa</surname><given-names>Minoru</given-names></name>
        <name><surname>Goto</surname><given-names>Susumu</given-names></name>
      </person-group>
      <article-title>KEGG database current statistics</article-title>
      <publisher-name>Kanehisa Laboratories</publisher-name>
      <year iso-8601-date="2025">2025</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-07-28">2025</year><month>07</month><day>28</day></date-in-citation>
      <uri>https://www.genome.jp/kegg/docs/statistics.html</uri>
    </element-citation>
  </ref>
  <ref id="ref-HAN2008483">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Han</surname><given-names>Xuemei</given-names></name>
        <name><surname>Aslanian</surname><given-names>Aaron</given-names></name>
        <name><surname>Yates</surname><given-names>John R</given-names></name>
      </person-group>
      <article-title>Mass spectrometry for proteomics</article-title>
      <source>Current Opinion in Chemical Biology</source>
      <year iso-8601-date="2008">2008</year>
      <volume>12</volume>
      <issue>5</issue>
      <issn>1367-5931</issn>
      <uri>https://www.sciencedirect.com/science/article/pii/S1367593108001178</uri>
      <pub-id pub-id-type="doi">10.1016/j.cbpa.2008.07.024</pub-id>
      <fpage>483</fpage>
      <lpage>490</lpage>
    </element-citation>
  </ref>
  <ref id="ref-gkh340">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Edgar</surname><given-names>Robert C.</given-names></name>
      </person-group>
      <article-title>MUSCLE: Multiple sequence alignment with high accuracy and high throughput</article-title>
      <source>Nucleic Acids Research</source>
      <year iso-8601-date="2004-03">2004</year><month>03</month>
      <volume>32</volume>
      <issue>5</issue>
      <issn>0305-1048</issn>
      <uri>https://doi.org/10.1093/nar/gkh340</uri>
      <pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id>
      <fpage>1792</fpage>
      <lpage>1797</lpage>
    </element-citation>
  </ref>
  <ref id="ref-gkf436">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Katoh</surname><given-names>Kazutaka</given-names></name>
        <name><surname>Misawa</surname><given-names>Kazuharu</given-names></name>
        <name><surname>Kuma</surname><given-names>Kei‐ichi</given-names></name>
        <name><surname>Miyata</surname><given-names>Takashi</given-names></name>
      </person-group>
      <article-title>MAFFT: A novel method for rapid multiple sequence alignment based on fast Fourier transform</article-title>
      <source>Nucleic Acids Research</source>
      <year iso-8601-date="2002-07">2002</year><month>07</month>
      <volume>30</volume>
      <issue>14</issue>
      <issn>0305-1048</issn>
      <uri>https://doi.org/10.1093/nar/gkf436</uri>
      <pub-id pub-id-type="doi">10.1093/nar/gkf436</pub-id>
      <fpage>3059</fpage>
      <lpage>3066</lpage>
    </element-citation>
  </ref>
  <ref id="ref-bi0313s48">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Sievers</surname><given-names>Fabian</given-names></name>
        <name><surname>Higgins</surname><given-names>Desmond G.</given-names></name>
      </person-group>
      <article-title>Clustal omega</article-title>
      <source>Current Protocols in Bioinformatics</source>
      <year iso-8601-date="2014">2014</year>
      <volume>48</volume>
      <issue>1</issue>
      <uri>https://currentprotocols.onlinelibrary.wiley.com/doi/abs/10.1002/0471250953.bi0313s48</uri>
      <pub-id pub-id-type="doi">10.1002/0471250953.bi0313s48</pub-id>
      <fpage>3.13.1</fpage>
      <lpage>3.13.16</lpage>
    </element-citation>
  </ref>
  <ref id="ref-Shannon6773024">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Shannon</surname><given-names>C. E.</given-names></name>
      </person-group>
      <article-title>A mathematical theory of communication</article-title>
      <source>The Bell System Technical Journal</source>
      <year iso-8601-date="1948">1948</year>
      <volume>27</volume>
      <issue>3</issue>
      <issn>0005-8580</issn>
      <pub-id pub-id-type="doi">10.1002/j.1538-7305.1948.tb01338.x</pub-id>
      <fpage>379</fpage>
      <lpage>423</lpage>
    </element-citation>
  </ref>
  <ref id="ref-Challen202100394">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Challen</surname><given-names>Bob</given-names></name>
        <name><surname>Cramer</surname><given-names>Rainer</given-names></name>
      </person-group>
      <article-title>Advances in ionisation techniques for mass spectrometry-based omics research</article-title>
      <source>PROTEOMICS</source>
      <year iso-8601-date="2022">2022</year>
      <volume>22</volume>
      <issue>15-16</issue>
      <uri>https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.202100394</uri>
      <pub-id pub-id-type="doi">10.1002/pmic.202100394</pub-id>
      <fpage>2100394</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
</ref-list>
</back>
</article>
